N3-(3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl)-1-(5,6,7,8,9,10-hexahydrocycloocta[d]-pyrimidin-2-yl)-1H-1,2,4-triazole-3,5-diamine | 1037310-96-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N3-(3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl)-1-(5,6,7,8,9,10-hexahydrocycloocta[d]-pyrimidin-2-yl)-1H-1,2,4-triazole-3,5-diamine
• 英文别名: N3-(3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl)-1-(5,6,7,8,9,10-hexahydrocycloocta[d]pyrimidin-2-yl)-1H-1,2,4-triazole-3,5-diamine；3-N-[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl]-1-(5,6,7,8,9,10-hexahydrocycloocta[d]pyrimidin-2-yl)-1,2,4-triazole-3,5-diamine
• CAS: 1037310-96-5
• 化学式: C₂₄H₃₂FN₉
• 分子量: 465.577
• InChiKey: NPCMDJNSMQDWGB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  34
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  101
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  2-hydrazinyl-5,6,7,8,9,10-hexahydrocycloocta[d]pyrimidine 、 (Z)-phenyl N'-cyano-N-(3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl)carbamimidate 以 N-甲基吡咯烷酮 为溶剂， 反应 0.17h， 生成 N3-(3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)phenyl)-1-(5,6,7,8,9,10-hexahydrocycloocta[d]-pyrimidin-2-yl)-1H-1,2,4-triazole-3,5-diamine
  参考文献：
  名称：

  WO2008/83353

  摘要：

  公开号：

文献信息

• BICYCLIC ARYL AND BICYCLIC HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS
  申请人：Goff Dane

  公开号：US20080188454A1

  公开（公告）日：2008-08-07

  Bicyclic aryl substituted triazoles or heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.

  本发明涉及双环芳基取代的三唑或杂环芳基取代的三唑，以及含有上述化合物的制药组合物，作为抑制受体蛋白酪氨酸激酶Axl活性的有用药物。还公开了使用这些化合物治疗与Axl活性相关的疾病或病况的方法。
• Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US07872000B2

  公开（公告）日：2011-01-18

  Bicyclic aryl substituted triazoles or heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.

  本发明涉及双环芳基取代的三唑或杂环芳基取代的三唑，以及含有这些化合物的药物组合物，被揭示为在抑制受体蛋白酪氨酸激酶Axl活性方面有用。还揭示了使用这些化合物治疗与Axl活性相关的疾病或病况的方法。
• Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US08809347B2

  公开（公告）日：2014-08-19

  Bicyclic aryl substituted triazoles or heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.

  本发明涉及双环芳基取代的三唑或杂环芳基取代的三唑，以及包含该化合物的药物组合物，用于抑制受体蛋白酪氨酸激酶Axl的活性，还公开了使用该化合物治疗与Axl活性相关的疾病或病状的方法。
• US7872000B2
  申请人：——

  公开号：US7872000B2

  公开（公告）日：2011-01-18
• US8492373B2
  申请人：——

  公开号：US8492373B2

  公开（公告）日：2013-07-23